“…To assess the implications of this competition for signaling output, we first validated that in our cell model system (U2OS cells), ACVR2/ALK4 transduce ActA signaling to Smad2/3, while BMP9 signaling to Smad1/5/8 employ ACVR2/ALK2 or ACVR2/ALK3. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Whole cell lysates from the selected clones exhibited anticancer effects against MCF-7 breast cancer cells (cell viability at 50% v/v was 46.2% ± 9.9 for 88-1G clone and 38% ± 7 for 102-5A clone), U2OS osteosarcoma cells (cell viability at 50% v/v was 64.6% ± 12.3 for 88-1G clone and 28.3% ± 1.7 for 102-5A clone) and 1BR hTERT human fibroblast cells (cell viability at 50% v/v was 74.4% ± 5.6 for 88-1G clone and 57.6% ± 8.9 for 102-5A clone). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The population of the remaining 25 counties varied from 1,953 to 110,074 inhabitants (median=23,862), median population density of 75.0 inhabitants/Km2 (interval 13.2–308.4 inhabitants/ Km2), median GIP of U$5,254,80 (interval U$2,234,80–U$20,747,40), and HDI values ranging from 145th to 2,282nd in the national ranking. …”
Enlace del recurso
Enlace del recurso

“…AML patients had significantly higher incidences of CEBPA, FLT3-ITD, DNMT3A, NPM1 and IDH1/2 gene mutations (p = 0.0043, 0.000, 0.030962, 0.002752, and 0.000628, respectively) and a lower incidence of TET2 and U2AF1 gene mutations (p = 0.000004 and 0.000, respectively) compared with MDS patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Non-SF3B1 gene mutations were TET2（16.7%）, ASXL1（14.3%）, U2AF1（11.1%）, TP53（7.9%）, SETBP1（6.3%）, and RUNX1（6.3%）. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This result of a non-parametric test, i.e. the Mann–Whitney U test revealed that project-supported facilities were higher and had a positive statistically significant difference (U = 2,728, z = -13.78, P = 0.001). CONCLUSIONS: The findings of this study underscore a direct relationship between implementing performance management innovations and enhancing organizational cultures for excellence at primary healthcare units. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Can Reduce participants were older (U=2.296, P=.02) and reported a greater number of cannabis use days at baseline than patients who entered outpatient treatment with cannabis as their main problem substance (data from the Swiss treatment demand monitoring statistics were used; chi-square [df 2]=4.0, P=.046). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Cellular gene symbols with large Chi square values from tryptic peptides included POTEB, CTNNA1, U2SURP, KIF24, NLGN2, KSR1, GTF2H1, KIT, RPS6KL1, VAV2, HSPA7, SMC2, TCEB3B, ZNF300, SUPV3L1, ADAMTS20, LAMB4, MCCC1, SUPT6H, SCN9A, SBNO1, EPHA1, ABLIM2, cB5E3.2, EPHA10, GRIN2B, HIVEP2, CCL16, TKT, LRP2 and TMF1 amongst others showed increased observation frequency. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…For adults with CRSE, insufficient evidence exists to support the effectiveness of LEV (level U; 2 class IV studies). Magnesium sulfate may be effective in the treatment of eclampsia, but there are only case reports of its use for CRSE. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Sex biases were observed at the single-gene level with mutations in seven genes enriched in men (ASXL1, SRSF2, and ZRSR2 p<0·0001 in both cohorts; DDX41 not available in the EuroMDS cohort vs p=0·0062 in the IWG-PM cohort; IDH2 p<0·0001 in EuroMDS vs p=0·042 in IWG-PM; TET2 p=0·031 vs p=0·035; U2AF1 p=0·033 vs p<0·0001) and mutations in two genes were enriched in women (DNMT3A p<0·0001 in EuroMDS vs p=0·011 in IWG-PM; TP53 p=0·030 vs p=0·037). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso